Dr. Reddy's Laboratories Limited - RDY

RDY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
RDY	0.5	-2.0	2.4	-6.5	-5.8	9.3	18.7	74.9	40.7	1375.2
S&P 500	1.0	3.7	2.1	2.3	8.2	25.4	31.0	80.6	196.5	33856.2

Compare RDY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	RDY
name	Dr. Reddy's Laboratories Limited
price	14.9
changes percentage	0.472
change	0.07
day low	14.81
day high	14.93
year high	16.892
year low	13.47
market cap	12412391807
price avg 50	14.83136
price avg 200	15.16858
exchange	NYSE
volume	1488994
avg volume	1355459
open	14.9
previous close	14.83
eps	0.77
pe	19.35
earnings announcement	2025-01-23T10:59:00.000+0000
shares outstanding	833046430
timestamp	2025-01-17 21:00:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 58.7%

Overall Quarterly Financial Health: 48.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001135951
revenue	279164000000	245879000000	13.54
gross profit	163607000000	202972000000	-19.39
gross profit ratio	0.59	0.83	-29.00
research and development expenses	22873000000	19381000000	18.02
operating expenses	95878000000	117615000000	-18.48
interest income	2278000000	1180000000	93.05
interest expense	1711000000	1428000000	19.82
ebitda	88422000000	74431000000	18.80
ebitdaratio	0.32	0.44	-28.41
operating income	67729000000	96282000000	-29.66
operating income ratio	0.24	0.39	-38.04
net income	55684000000	45067000000	23.56
net income ratio	0.2	0.18	8.83
eps	334.02	271.47	23.04

Overall Score of Annual Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 279,164 million in 2024 from 245,879 million in 2023 representing a change of 13.54%. This indicates a sales growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 22,873 million in 2024 from 19,381 million in 2023 representing a change of 18.02%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 88,422 million in 2024 from 74,431 million in 2023 representing a change of 18.8%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 55,684 million in 2024 from 45,067 million in 2023 representing a change of 23.56%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 334.02 in 2024 from 334.02 in 2023 representing a change of 23.04%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 163,607 million in 2024 from 202,972 million in 2023 representing a change of -19.39%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 95,878 million in 2024 from 117,615 million in 2023 representing a change of -18.48%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 67,729 million in 2024 from 96,282 million in 2023 representing a change of -29.66%. The decrease in operating income indicates worse operational performance and decreased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q2	2025Q1	Q/Q change %
0001135951
revenue	80162000000	76727000000	4.48
gross profit	47769000000	46344000000	3.07
gross profit ratio	0.6	0.6	-1.34
research and development expenses	7271000000	6193000000	17.41
operating expenses	30218000000	28419000000	6.33
interest income	665000000	0	NaN
interest expense	757000000	0	NaN
ebitda	23899000000	21757000000	9.85
ebitdaratio	0.3	0.28	5.14
operating income	17551000000	17925000000	-2.09
operating income ratio	0.22	0.23	-6.28
net income	12553000000	13920000000	-9.82
net income ratio	0.16	0.18	-13.68
eps	0	83.46	-100.00

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 80,162 million in 2025Q2 from 76,727 million in 2025Q1 representing a change of 4.48%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 47,769 million in 2025Q2 from 46,344 million in 2025Q1 representing a change of 3.07%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 7,271 million in 2025Q2 from 6,193 million in 2025Q1 representing a change of 17.41%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 23,899 million in 2025Q2 from 21,757 million in 2025Q1 representing a change of 9.85%. The increase in EBITDA indicates improved operational efficiency and profitability.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 30,218 million in 2025Q2 from 28,419 million in 2025Q1 representing a change of 6.33%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 17,551 million in 2025Q2 from 17,925 million in 2025Q1 representing a change of -2.09%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 12,553 million in 2025Q2 from 13,920 million in 2025Q1 representing a change of -9.82%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0 in 2025Q2 from 0 in 2025Q1 representing a change of -100.0%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001135951
total assets	387518000000	322851000000	20.03
total liabilities	106968000000	89990000000	18.87
total equity	280550000000	232861000000	20.48
cash and cash equivalents	7107000000	5779000000	22.98
short term investments	74363000000	60969000000	21.97
long term investments	5255000000	6089000000	-13.70
total current assets	248049000000	204255000000	21.44
total non current assets	139469000000	118596000000	17.60
total current liabilities	96039000000	85721000000	12.04
total non current liabilities	10929000000	4269000000	156.01
common stock	834000000	833000000	0.12
retained earnings	265257000000	215593000000	23.04
total debt	20020000000	13472000000	48.60

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 387,518 million in 2024 from 322,851 million in 2023 representing a change of 20.03%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 280,550 million in 2024 from 232,861 million in 2023 representing a change of 20.48%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 7,107 million in 2024 from 5,779 million in 2023 representing a change of 22.98%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 74,363 million in 2024 from 60,969 million in 2023 representing a change of 21.97%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 248,049 million in 2024 from 204,255 million in 2023 representing a change of 21.44%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 834 in 2024 from 833 in 2023 representing a change of 0.12%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 265,257 million in 2024 from 215,593 million in 2023 representing a change of 23.04%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 106,968 million in 2024 from 89,990 million in 2023 representing a change of 18.87%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 96,039 million in 2024 from 85,721 million in 2023 representing a change of 12.04%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 20,020 million in 2024 from 13,472 million in 2023 representing a change of 48.6%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q2	2025Q1	Q/Q change %
0001135951
total assets	465955000000	415297000000	12.20
total liabilities	156672000000	120670000000	29.84
total equity	309283000000	294627000000	4.97
cash and cash equivalents	11330000000	4913000000	130.61
short term investments	51744000000	89713000000	-42.32
long term investments	5979000000	5209000000	14.78
total current assets	248128000000	269188000000	-7.82
total non current assets	217827000000	146109000000	49.09
total current liabilities	129299000000	105673000000	22.36
total non current liabilities	27373000000	14997000000	82.52
common stock	834000000	834000000	0.00
retained earnings	285180000000	279830000000	1.91
total debt	48540000000	30675000000	58.24

Overall Score of Quarterly Balance Sheet

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 465,955 million in 2025Q2 from 415,297 million in 2025Q1 representing a change of 12.2%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 309,283 million in 2025Q2 from 294,627 million in 2025Q1 representing a change of 4.97%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 11,330 million in 2025Q2 from 4,913 million in 2025Q1 representing a change of 130.61%. This indicates an increase in available liquid assets.

  Retained Earnings: Retained Earnings increased to 285,180 million in 2025Q2 from 279,830 million in 2025Q1 representing a change of 1.91%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 156,672 million in 2025Q2 from 120,670 million in 2025Q1 representing a change of 29.84%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 51,744 million in 2025Q2 from 89,713 million in 2025Q1 representing a change of -42.32%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 248,128 million in 2025Q2 from 269,188 million in 2025Q1 representing a change of -7.82%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 129,299 million in 2025Q2 from 105,673 million in 2025Q1 representing a change of 22.36%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 48,540 million in 2025Q2 from 30,675 million in 2025Q1 representing a change of 58.24%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001135951
net change in cash	1328000000	-9073000000	114.64
operating cash flow	45433000000	58873000000	-22.83
free cash flow	17998000000	40009000000	-55.02
capital expenditure	-27435000000	-18864000000	-45.44
depreciation and amortization	14841000000	12502000000	18.71
deferred income tax	16186000000	15300000000	5.79
stock based compensation	821000000	397000000	106.80
accounts payables	0	5752000000	-100.00
inventory	-18445000000	-2654000000	-594.99
acquisitions net	-12000000	0	NaN
investments in property plant and equipment	-16403000000	-18864000000	13.05
net cash used for investing activites	-40283000000	-41371000000	2.63
debt repayment	-1147000000	-1015000000	-13.00
common stock issued	805000000	368000000	118.75
common stock repurchased	0	0	NaN
dividends paid	-6648000000	-4979000000	-33.52
net cash used provided by financing activities	-3763000000	-26861000000	85.99
cash at end of period	7107000000	5779000000	22.98
accounts receivables	-8054000000	-5752000000	-40.02
cash at beginning of period	5779000000	14852000000	-61.09

Overall Score of Annual Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 1,328 million in 2024 from -9,073 million in 2023 representing a change of 114.64%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -27,435 million in 2024 from -18,864 million in 2023 representing a change of -45.44%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024 from 5,752 million in 2023 representing a change of -100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -8,054 million in 2024 from -5,752 million in 2023 representing a change of -40.02%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 45,433 million in 2024 from 58,873 million in 2023 representing a change of -22.83%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 17,998 million in 2024 from 40,009 million in 2023 representing a change of -55.02%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to 16,186 million in 2024 from 15,300 million in 2023 representing a change of 5.79%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 821 million in 2024 from 397 million in 2023 representing a change of 106.8%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Dividends Paid: Dividends Paid decreased to -6,648 million in 2024 from -4,979 million in 2023 representing a change of -33.52%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q2	2025Q1	Q/Q change %
0001135951
operating cash flow	9316000000	8496000000	9.65
free cash flow	1407000000	2072000000	-32.09
capital expenditure	-7909000000	-6424000000	-23.12
depreciation and amortization	3975000000	3810000000	4.33
deferred income tax	5752000000	4901000000	17.36
stock based compensation	107000000	101000000	5.94
accounts receivables	-3396000000	-786000000	-332.06
accounts payables	0	0	NaN
inventory	-5008000000	-6323000000	20.80
acquisitions net	0	0	NaN
investments in property plant and equipment	-7536000000	-5110000000	-47.48
net cash used for investing activites	-19071000000	-20248000000	5.81
debt repayment	16555000000	10266000000	61.26
common stock issued	7194000000	19000000	37763.16
common stock repurchased	0	0	NaN
dividends paid	-6662000000	0	NaN
net cash used provided by financing activities	16150000000	9541000000	69.27
net change in cash	6372000000	-2194000000	390.43
cash at end of period	11285000000	4913000000	129.70
cash at beginning of period	4913000000	7107000000	-30.87

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 6,372 million in 2025Q2 from -2,194 million in 2025Q1 representing a change of 390.43%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 9,316 million in 2025Q2 from 8,496 million in 2025Q1 representing a change of 9.65%. This indicates that the company generated more cash from its core business operations.

  Capital Expenditure: Capital Expenditure decreased to -7,909 million in 2025Q2 from -6,424 million in 2025Q1 representing a change of -23.12%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -3,396 million in 2025Q2 from -786 million in 2025Q1 representing a change of -332.06%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Free Cash Flow: Free Cash Flow decreased to 1,407 million in 2025Q2 from 2,072 million in 2025Q1 representing a change of -32.09%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to 5,752 million in 2025Q2 from 4,901 million in 2025Q1 representing a change of 17.36%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 107 million in 2025Q2 from 101 million in 2025Q1 representing a change of 5.94%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Dividends Paid: Dividends Paid decreased to -6,662 million in 2025Q2 from 0 million in 2025Q1 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q2 2025 Earnings call transcript
Q4 2024 Earnings call transcript
Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-03-31	2023-03-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	335.55	1480.89	-77.34
net income per share	66.93	271.43	-75.34
operating cash flow per share	54.61	354.58	-84.60
free cash flow per share	21.63	240.97	-91.02
cash per share	97.92	402.01	-75.64
book value per share	337.21	1402.48	-75.96
tangible book value per share	287.69	1184.47	-75.71
shareholders equity per share	337.21	1402.48	-75.96
interest debt per share	26.12	89.74	-70.89
market cap	1040018881546.05	153507557549.5	577.50
enterprise value	1052931881546.05	161200557549.5	553.18
pe ratio	18.68	3.41	448.33
price to sales ratio	3.73	0.62	496.72
pocfratio	22.89	2.61	777.92
pfcf ratio	57.79	3.84	1406.07
pb ratio	3.71	0.66	462.34
ptb ratio	3.71	0.66	462.34
ev to sales	3.77	0.66	475.30
enterprise value over ebitda	11.93	2.18	448.01
ev to operating cash flow	23.18	2.74	746.41
ev to free cash flow	58.5	4.03	1352.00
earnings yield	0.05	0.29	-81.76
free cash flow yield	0.02	0.26	-93.36
debt to equity	0.07	0.06	23.34
debt to assets	0.05	0.04	23.81
net debt to ebitda	0.15	0.1	40.83
current ratio	2.58	2.38	8.39
interest coverage	39.58	40.02	-1.08
income quality	0.82	0.97	-16.18
dividend yield	0.01	0.03	-80.29
payout ratio	0.12	0.11	8.06
sales general and administrative to revenue	0	0.19	-100.00
research and ddevelopement to revenue	0.08	0.08	3.95
intangibles to total assets	0.11	0.11	-5.17
capex to operating cash flow	0.6	0.32	88.46
capex to revenue	0.1	0.08	28.10
capex to depreciation	1.85	1.51	22.51
stock based compensation to revenue	0.0	0.0	-9.70
graham number	712.61	2926.64	-75.65
roic	0.17	0.17	0.57
return on tangible assets	0.16	0.16	2.27
graham net net	79.93	334.01	-76.07
working capital	152010000000	118534000000	28.24
tangible asset value	239346000000	196663000000	21.70
net current asset value	141081000000	114265000000	23.47
invested capital	270100000000	211274000000	27.84
average receivables	76391500000	76377500000	0.02
average payables	19702000000	16914000000	16.48
average inventory	56111000000	49777000000	12.72
days sales outstanding	104.99	107.6	-2.43
days payables outstanding	68.06	85.11	-20.04
days of inventory on hand	200.74	231.98	-13.47
receivables turnover	3.48	3.39	2.49
payables turnover	5.36	4.29	25.06
inventory turnover	1.82	1.57	15.57
roe	0.2	0.19	2.56
capex per share	32.98	113.61	-70.98

• Positive

  ROE: Return on Equity (ROE) increased to 0.20 on 2024-03-31 from 0.19 on 2023-03-31, representing a change of 2.56%. Suggesting the company has been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 18.68 on 2024-03-31 from 3.41 on 2023-03-31, representing a change of 448.33%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 2.58 on 2024-03-31 from 2.38 on 2023-03-31, representing a change of 8.39%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.07 on 2024-03-31 from 0.06 on 2023-03-31, representing a change of 23.34%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q2	2024-06-30 Q1	Q/Q change %
RDY
calendar year	2024	2024	NaN
revenue per share	96.07	460.7	-79.15
net income per share	15.04	83.58	-82.00
operating cash flow per share	11.17	49.22	-77.32
free cash flow per share	1.69	10.65	-84.17
cash per share	75.59	568.17	-86.70
book value per share	370.67	1769.05	-79.05
tangible book value per share	246.16	1520.62	-83.81
shareholders equity per share	365.95	1769.05	-79.31
interest debt per share	59.08	187.77	-68.54
market cap	1126686388613.6	211635885076.38	432.37
enterprise value	1163896388613.6	237397885076.38	390.27
pe ratio	22.44	3.8	490.34
price to sales ratio	14.06	2.76	409.56
pocfratio	120.94	25.82	368.48
pfcf ratio	800.77	119.3	571.23
pb ratio	3.69	0.72	413.69
ptb ratio	3.69	0.72	413.69
ev to sales	14.52	3.09	369.26
enterprise value over ebitda	48.83	10.91	347.47
ev to operating cash flow	124.94	28.96	331.44
ev to free cash flow	827.22	133.82	518.15
earnings yield	0.01	0.07	-83.06
free cash flow yield	0.0	0.01	-85.10
debt to equity	0.16	0.1	52.69
debt to assets	0.1	0.07	41.04
net debt to ebitda	1.56	1.18	31.83
current ratio	1.92	2.55	-24.67
interest coverage	23.18	29.33	-20.96
income quality	0.74	0.59	26.01
dividend yield	0.01	0	NaN
payout ratio	0.53	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.09	0.08	12.92
intangibles to total assets	0.22	0.1	123.80
capex to operating cash flow	0.85	0.78	8.34
capex to revenue	0.1	0.08	17.84
capex to depreciation	1.99	1.69	18.01
stock based compensation to revenue	0	0.0	-100.00
graham number	351.96	1823.96	-80.70
roic	0.03	0.04	-16.19
return on tangible assets	0.03	0.04	-6.87
graham net net	13.6	414.64	-96.72
working capital	118829000000	163515000000	-27.33
tangible asset value	205391000000	253253000000	-18.90
net current asset value	91456000000	148518000000	-38.42
invested capital	309414000000	285232000000	8.48
average receivables	86495500000	80693000000	7.19
average payables	34942500000	27828000000	25.57
average inventory	70303500000	66060000000	6.42
days sales outstanding	103.18	95.12	8.48
days payables outstanding	93.11	94.45	-1.42
days of inventory on hand	187.49	189.87	-1.26
receivables turnover	0.87	0.95	-7.82
payables turnover	0.97	0.95	1.44
inventory turnover	0.48	0.47	1.27
roe	0.04	0.05	-12.99
capex per share	9.48	38.57	-75.43

• Negative

  ROE: Return on Equity (ROE) decreased to 0.04 on 2024-09-30 Q2 from 0.05 on 2024-06-30 Q1, representing a change of -12.99%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 22.44 on 2024-09-30 Q2 from 3.80 on 2024-06-30 Q1, representing a change of 490.34%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.92 on 2024-09-30 Q2 from 2.55 on 2024-06-30 Q1, representing a change of -24.67%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.16 on 2024-09-30 Q2 from 0.10 on 2024-06-30 Q1, representing a change of 52.69%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None